Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

For at least the third time in the last two months, San Francisco law enforcement raided an open-air drug market where ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

The National Agency for Food and Drug Administration and Control (NAFDAC) on Friday destroyed fake, counterfeit and ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

The researchers found that drug seizures in San Francisco were associated with a substantial increase in fatal opioid ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

An entrenched and escalating drug market is creating chronic public safety issues in Seattle’s University District, according ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...